bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) rose 20.6% on Thursday . The stock traded as high as $0.34 and last traded at $0.34. Approximately 1 shares changed hands during trading, a decline of 100% from the average daily volume of 1,833 shares. The stock had previously closed at $0.2819.
bioAffinity Technologies Trading Down 2.1%
The company’s 50 day moving average price is $0.30 and its 200-day moving average price is $0.25.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Further Reading
- Five stocks we like better than bioAffinity Technologies
- A U.S. “birthright” claim worth trillions – activated quietly
- Trump’s AI Secret: 100X Faster Than Nvidia
- Buy This Stock at 9:30 AM on MONDAY!
- HUGE gold prediction
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
